Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 28, 2026

Three-Dimensional Reconstruction of Orbital Fractures
08:18

Three-Dimensional Reconstruction of Orbital Fractures

Published on: May 16, 2025

967

Life expectancy following orbital exenteration.

James Chiun Lon Wong1, Reshma Thampy2, Anne Cook2

  • 1Manchester Medical School, Manchester, UK.

The British Journal of Ophthalmology
|June 1, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of ophthalmic referral diagnoses by non-ophthalmologists in acute eye care: protocol for a systematic review and meta-analysis.

BMJ open·2026
Same author

Periorbital necrotizing fasciitis: the Manchester experience.

BMC ophthalmology·2025
Same author

Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.

The Journal of clinical endocrinology and metabolism·2023
Same author

Utility of a personalised <i>B</i>ronchiectasis <i>A</i>ction <i>M</i>anagement <i>P</i>lan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trial.

BMJ open·2021
Same author

Complete manuscript title: Neurological complications from sinugenic orbital cellulitis.

European journal of ophthalmology·2021
Same author

Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial.

The Lancet. Respiratory medicine·2021
Same journal

Identifying patients with poor visual outcomes after primary rhegmatogenous retinal detachment surgery using machine learning.

The British journal of ophthalmology·2026
Same journal

Incidence of bilateral disease and choroidal neovascularisation in punctate inner choroiditis.

The British journal of ophthalmology·2026
Same journal

Reference map of multimodal vision deficits in intermediate age-related macular degeneration: contrast sensitivity and low-contrast visual acuity.

The British journal of ophthalmology·2026
Same journal

Commentary on 'identifying patients with poor visual outcomes after primary rhegmatogenous retinal detachment surgery using machine learning'.

The British journal of ophthalmology·2026
Same journal

Automated deep learning-based retinoschisis and detachment volume measurement in pathological myopia with posterior scleral contraction.

The British journal of ophthalmology·2026
Same journal

Bacterial keratitis: a global review of current practices, challenges and innovations.

The British journal of ophthalmology·2026
See all related articles

Orbital exenteration for malignancy has a poor prognosis, with a 5-year survival rate of 64%. Basal cell carcinoma (BCC) significantly improves survival compared to other orbital malignancies. Multidisciplinary care is crucial for optimizing outcomes.

Area of Science:

  • Ophthalmology
  • Oncology
  • Surgical Oncology

Background:

  • Orbital exenteration is a radical surgical procedure for orbital malignancy.
  • Patient counseling requires accurate life expectancy data.
  • A multidisciplinary approach is essential for managing these complex cases.

Purpose of the Study:

  • To evaluate the survival rates of patients undergoing orbital exenteration for malignancy.
  • To identify prognostic factors influencing survival.
  • To assess the impact of specific cancer types and surgical margins on outcomes.

Main Methods:

  • Retrospective review of patients who underwent orbital exenteration for malignancy (1998-2010).
  • Data sourced from a tertiary care center and ICD-10 database.
Keywords:
CosmesisNeoplasiaProsthesisRehabilitationTreatment Surgery

More Related Videos

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

2.1K
Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction
06:32

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction

Published on: December 5, 2025

902

Related Experiment Videos

Last Updated: Apr 28, 2026

Three-Dimensional Reconstruction of Orbital Fractures
08:18

Three-Dimensional Reconstruction of Orbital Fractures

Published on: May 16, 2025

967
Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

2.1K
Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction
06:32

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction

Published on: December 5, 2025

902
  • Survival analysis using Kaplan-Meier curves and statistical software.

    • Main Results:

    • The overall 5-year survival rate was 64%.
    • Basal cell carcinoma (BCC) showed significantly better survival than non-BCC (p=0.0199).
    • Cleared surgical margins did not significantly impact survival (p=0.2890).

    Conclusions:

    • Despite the highest 5-year survival data reported, the overall prognosis for orbital exenteration remains poor.
    • Survival is influenced by malignancy type, with BCC offering a better outlook.
    • A multidisciplinary team approach is recommended to optimize care and outcomes for patients.